Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Launching of EHealth Lebanon Mobile App. for MoPH Digital Services

 
Caretaker Deputy Prime Minister and Health Minister Ghassan Hasbani launched EHealth Lebanon mobile App for the MOPH  digital services. This project is the product of collaboration between the Ministry of Public Health and Loubnaniyoun Association, knowing that the Ministry has not incurred any financial costs. The launching ceremony was attended by the head of the Lebanese Order of Physicians in Beirut Pr. Raymond Sayegh, the Syndicate of Private Hospitals President Suleiman Haroun, the President of the Syndicate of Nurseries in Lebanon Hana Joujou, representatives of Loubnaniyoun Association, Dr. Guy Hokayem, Mrs. Katia Mansour, the National E-health Programme Director Lina Abou Mrad and concerned parties.
 
Abou Mrad opened the launching ceremony by introducing the MOPH’s process of facilitating the administrative procedures back from 2000 to date. In this context, several projects were completed to end up with the digital services. She also mentioned the different strategic initiatives of the Ministry within “Health 2025” Plan, which are: digital complaint reporting, the electronic medical record (EMR), custom registration, Drug barcode system, the One stop Shop, and e-government services.
 
Mrs. Mrad delivered a technical presentation on EHealth Lebanon mobile application, during which she introduced the different digitized services that are available to all the citizens on the digital platform that was developed to this end.
 
Minister Hasbani noted that launching the digital services is considered as a new step in the service of the Lebanese citizen. The role of the Ministry of Public Health encompasses not only the medical services provision, but also the supervision and registration of the medical professions, drug warehouses and the companies that import them. Hasbani added that all the transactions are now electronically available.  
 
 “The implementation of the project will take a long time, since the administrative services will be provided in parallel with the electronic ones for the citizens to get used to the digital services,” noted Hasbani.

“This project aims at keeping up with the evolving human competences of the physicians and medical professions workers”, said Hasbani.
    ...
    6
ATC Name B/G Ingredients Dosage Form Price
C10AA07 ROXARDIO G Rosuvastatin (calcium) - 20mg 20mg Tablet, film coated 720,525 L.L
C10AA07 ROSUCOR G Rosuvastatin (calcium) - 40mg 40mg Tablet, film coated 487,623 L.L
A02BC04 RABEC G Rabeprazole (sodium) - 10mg 10mg Tablet, film coated 212,327 L.L
C10AA07 ROSUPHAR G Rosuvastatin (calcium) - 40mg 40mg Tablet, film coated 487,623 L.L
A02BC04 RAMEP G Rabeprazole (sodium) - 10mg 10mg Tablet, gastroresistant 795,310 L.L
C10AA07 ROXARDIO G Rosuvastatin (calcium) - 40mg 40mg Tablet, film coated 720,525 L.L
C10AA07 ROSUCOR G Rosuvastatin (calcium) - 5mg 5mg Tablet, film coated 360,918 L.L
C10AA07 ROSUPHAR G Rosuvastatin (calcium) - 5mg 5mg Tablet, film coated 360,918 L.L
A02BC04 RABEC G Rabeprazole (sodium) - 20mg 20mg Tablet, film coated 212,327 L.L
M03AC09 ROCUCELL G Rocuronium bromide - 50mg/5ml 50mg/5ml Injectable solution 3,633,494 L.L
A02BC04 RABEZOL 20 G Rabeprazole sodium - 20mg 20mg Tablet, enteric coated 282,847 L.L
A02BC04 RABEZOL 20 G Rabeprazole sodium - 20mg 20mg Tablet, enteric coated 639,925 L.L
A02BC04 RAMEP G Rabeprazole (sodium) - 20mg 20mg Tablet, gastroresistant 499,046 L.L
A02BC04 RAZOLE 20 G Rabeprazole sodium - 20mg 20mg Tablet, enteric coated 282,847 L.L
R03DC03 RELIEFAST G Montelukast (sodium) - 5mg 5mg Tablet, chewable 1,034,119 L.L
A02BC04 RAZOLE 20 G Rabeprazole sodium - 20mg 20mg Tablet, enteric coated 639,925 L.L
R03DC03 ROMILAST G Montelukast (sodium) - 5mg 5mg Tablet, mouth dissolving 518,723 L.L
N02BE51 RHINOSTOP G Paracetamol - 500mg, Chlorphenamine maleate - 4mg, Phenylephrine HCl - 5mg Tablet, film coated 534,977 L.L
N06DA03 RIVASTIGMINE ARROW G Rivastigmine - 3mg 3mg Capsule 842,589 L.L
N06DA03 RIVASTIGMINE ARROW G Rivastigmine - 3mg 3mg Capsule 842,589 L.L
N06DA03 RIVASTIGMINE ARROW G Rivastigmine - 1.5mg 1.5mg Capsule 684,016 L.L
N05AH04 REZAL XR G Quetiapine fumarate - 200mg 200mg Tablet, extended release 2,116,552 L.L
N06DA03 RIVASTIGMINE ARROW G Rivastigmine - 1.5mg 1.5mg Capsule 684,016 L.L
R03DC03 RELIEFAST G Montelukast (sodium) - 10mg 10mg Tablet, film coated 844,701 L.L
R03DC03 ROMILAST G Montelukast (sodium) - 10mg 10mg Tablet, film coated 228,453 L.L
C10AC01 RESINCOLESTIRAMINA G Cholestyramine - 4g 4g Powder for suspension 2,998,113 L.L
J01DD04 ROCICARE G Ceftriaxone - 1g 1g Injectable powder for solution 9,382,061 L.L
N05AH04 REZAL XR G Quetiapine fumarate - 300mg 300mg Tablet, extended release 2,535,831 L.L
N02BE51 REMIDOL G Paracetamol - 650mg, Dextromethorphan HBr - 20mg, Chlorphenamine maleate - 4mg Granules for solution 537,537 L.L
N06DA03 RIVASTIGMINE ARROW G Rivastigmine - 4.5mg 4.5mg Capsule 842,589 L.L
    ...
    6
Sitemap
© Copyrights reserved to Ministry of Public Health 2025